Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single 
activity and combination with other antileukemic drugs.

Fiegl, M.; Lindner, L. H.; Juergens, M.; Eibl, H.; Hiddemann, W.; Braess, J.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs.

MPS-Authors

/persons/resource/persons15029

Eibl, H.
Research Group of Phospholipids, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Fiegl, M., Lindner, L. H., Juergens, M., Eibl, H., Hiddemann, W., & Braess, J. (2008). Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs. Cancer Chemotherapy and Pharmacology, 62(2), 321-329. Retrieved from http://springerlink.metapress.com/content/v275q06mt983t646/fulltext.html.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0012-DB87-D

Abstract

There is no abstract available